journal article·2023-10-25

Nanopore Signatures of Nucleoside Drugs

Wendong Jia, Yusheng Ouyang, Shanyu Zhang, Xiaoyu Du, Panke Zhang, Shuo Huang

Nano Letters· Volume 23· Issue 20
Publisher page

Abstract

Nucleoside drugs, which are analogues of natural nucleosides, have been widely applied in the clinical treatment of viral infections and cancers. The development of nucleoside drugs, repurposing of existing drugs, and combined use of multiple drug types have made the rapid sensing of nucleoside drugs urgently needed. Nanopores are emerging single-molecule sensors that have high resolution to resolve even minor structural differences between chemical compounds. Here, an engineered Mycobacterium smegmatis porin A hetero-octamer was used to perform general nucleoside drug analysis. Ten nucleoside drugs were simultaneously detected and fully discriminated. An accuracy of >99.9% was consequently reported. This sensing capacity was further demonstrated in direct nanopore analysis of ribavirin buccal tablets, confirming its sensing reliability against complex samples and environments. No sample separation is needed, however, significantly minimizing the complexity of the measurement. This technique may inspire nanopore applications in pharmaceutical production and pharmacokinetics measurements.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanopore and Nanochannel Transport Studies · Microfluidic and Capillary Electrophoresis Applications · Advanced biosensing and bioanalysis techniques

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

State Key Laboratory of Analytical Chemistry for Life Sciences, School of Chemistry and Chemical Engineering, Nanjing University, 210023 Nanjing, China

Chemistry and Biomedicine Innovation Center (ChemBIC), Nanjing University, 210023 Nanjing, China

Funding

State Key Laboratory of Analytical Chemistry for Life Sciences · National Key Research and Development Program of China · China Postdoctoral Science Foundation · High Level Innovation and Entrepreneurial Research Team Program in Jiangsu · Government of Jiangsu Province · Science Fund for Distinguished Young Scholars of Jiangsu Province · Nanjing University · Fundamental Research Funds for the Central Universities · National Natural Science Foundation of China

References (53)

Show source-provided references
1. 10.1128/CMR.00102-1510.1128/CMR.00102-15 ↗
2. 10.3390/molecules2509205010.3390/molecules25092050 ↗
3. 10.1038/nrd401010.1038/nrd4010 ↗
4. 10.1002/phar.242910.1002/phar.2429 ↗
5. 10.1056/NEJMoa211604410.1056/NEJMoa2116044 ↗
6. 10.1002/advs.20200143510.1002/advs.202001435 ↗
7. 10.3390/molecules2604098610.3390/molecules26040986 ↗
8. 10.1016/j.antiviral.2018.04.00410.1016/j.antiviral.2018.04.004 ↗
9. 10.1093/jac/dkx15110.1093/jac/dkx151 ↗
10. 10.1186/1752-1947-8-28110.1186/1752-1947-8-281 ↗
11. 10.1159/00033199510.1159/000331995 ↗
12. 10.1007/s12250-020-00276-510.1007/s12250-020-00276-5 ↗
13. 10.1007/s10461-020-02983-210.1007/s10461-020-02983-2 ↗
14. 10.1016/j.jpba.2007.06.00410.1016/j.jpba.2007.06.004 ↗
15. 10.1016/j.cca.2011.07.01610.1016/j.cca.2011.07.016 ↗
16. 10.1016/j.cca.2014.03.01610.1016/j.cca.2014.03.016 ↗
17. 10.1093/jac/dkaa15210.1093/jac/dkaa152 ↗
18. 10.1016/j.jchromb.2021.12292110.1016/j.jchromb.2021.122921 ↗
19. 10.1038/nbt.217110.1038/nbt.2171 ↗
20. 10.1038/nmeth.457710.1038/nmeth.4577 ↗
21. 10.1038/s41565-022-01193-210.1038/s41565-022-01193-2 ↗
22. 10.1002/anie.20120568710.1002/anie.201205687 ↗
23. 10.1002/anie.20220376910.1002/anie.202203769 ↗
24. 10.1007/s11426-018-9231-210.1007/s11426-018-9231-2 ↗
25. 10.1186/s43556-021-00026-310.1186/s43556-021-00026-3 ↗
26. 10.1021/acssensors.8b0164510.1021/acssensors.8b01645 ↗
27. 10.1021/ja202608510.1021/ja2026085 ↗
28. 10.1038/1949110.1038/19491 ↗
29. 10.1038/s41467-019-13677-210.1038/s41467-019-13677-2 ↗
30. 10.1038/s41467-021-26054-910.1038/s41467-021-26054-9 ↗
31. 10.1021/acssensors.2c0044710.1021/acssensors.2c00447 ↗
32. 10.1517/14656566.2.8.131710.1517/14656566.2.8.1317 ↗
33. 10.1002/prp2.94510.1002/prp2.945 ↗
34. 10.1016/j.bbrc.2005.03.06210.1016/j.bbrc.2005.03.062 ↗
35. 10.1080/mccm.6.4.171.17610.1080/mccm.6.4.171.176 ↗
36. 10.1016/S0166-3542(02)00185-710.1016/S0166-3542(02)00185-7 ↗
37. 10.1038/sj.onc.120569910.1038/sj.onc.1205699 ↗
38. Houghton J. A. · Cancer Res. · 1979 · 39 · 2406
39. 10.1371/journal.pone.002327110.1371/journal.pone.0023271 ↗
40. 10.1081/NCN-20005976510.1081/NCN-200059765 ↗
41. 10.1517/13543784.2013.84297410.1517/13543784.2013.842974 ↗
42. 10.1039/c3cs60038f10.1039/c3cs60038f ↗
43. 10.1021/ac702057u10.1021/ac702057u ↗
44. 10.1016/S0006-3495(00)76445-910.1016/S0006-3495(00)76445-9 ↗
45. 10.1073/pnas.23143469810.1073/pnas.231434698 ↗
46. 10.1002/cbic.20050006410.1002/cbic.200500064 ↗
47. 10.1002/anie.20090660110.1002/anie.200906601 ↗
48. 10.1016/j.antiviral.2021.10518010.1016/j.antiviral.2021.105180 ↗
49. 10.2217/fon.10.8310.2217/fon.10.83 ↗
50. 10.1517/1465656080259445910.1517/14656560802594459 ↗
51. 10.1002/jmv.2579810.1002/jmv.25798 ↗
52. 10.1021/jacs.2c0459510.1021/jacs.2c04595 ↗
53. 10.1038/s41565-022-01169-210.1038/s41565-022-01169-2 ↗